201 related articles for article (PubMed ID: 34990928)
1. A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity.
Xiao M; Tang Y; Wang J; Lu G; Niu J; Wang J; Li J; Liu Q; Wang Z; Huang Z; Guo Y; Gao T; Zhang X; Yue S; Gu J
Redox Biol; 2022 Feb; 49():102219. PubMed ID: 34990928
[TBL] [Abstract][Full Text] [Related]
2. FGF1
Wang D; Jin M; Zhao X; Zhao T; Lin W; He Z; Fan M; Jin W; Zhou J; Jin L; Zheng C; Jin H; Zhao Y; Li X; Ying L; Wang Y; Zhu G; Huang Z
Cell Death Dis; 2019 Jun; 10(6):464. PubMed ID: 31189876
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway.
Lu G; Liu Q; Gao T; Li J; Zhang J; Chen O; Cao C; Mao M; Xiao M; Zhang X; Wang J; Guo Y; Tang Y; Gu J
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235670
[TBL] [Abstract][Full Text] [Related]
4. FGF1
Lin Q; Chen O; Wise JP; Shi H; Wintergerst KA; Cai L; Tan Y
Biochim Biophys Acta Mol Basis Dis; 2022 Aug; 1868(8):166414. PubMed ID: 35447340
[TBL] [Abstract][Full Text] [Related]
5. Davallialactone protects against adriamycin-induced cardiotoxicity in vitro and in vivo.
Arunachalam S; Kim SY; Lee SH; Lee YH; Kim MS; Yun BS; Yi HK; Hwang PH
J Nat Med; 2012 Jan; 66(1):149-57. PubMed ID: 21858697
[TBL] [Abstract][Full Text] [Related]
6. FGF1
Wang D; Yin Y; Wang S; Zhao T; Gong F; Zhao Y; Wang B; Huang Y; Cheng Z; Zhu G; Wang Z; Wang Y; Ren J; Liang G; Li X; Huang Z
Signal Transduct Target Ther; 2021 Mar; 6(1):133. PubMed ID: 33762571
[TBL] [Abstract][Full Text] [Related]
7. Protective effects and mechanisms of psoralidin against adriamycin-induced cardiotoxicity.
Liang Z; Chen Y; Wang Z; Wu X; Deng C; Wang C; Yang W; Tian Y; Zhang S; Lu C; Yang Y
J Adv Res; 2022 Sep; 40():249-261. PubMed ID: 36100330
[TBL] [Abstract][Full Text] [Related]
8. Fasudil Protects Against Adriamycin-induced Acute Heart Injury by Inhibiting Oxidative Stress, Apoptosis, and Cellular Senescence.
Yan Y; Xiang C; Zhang D
Curr Pharm Des; 2022; 28(29):2426-2435. PubMed ID: 35909282
[TBL] [Abstract][Full Text] [Related]
9. Protective effects and mechanisms of lycorine against adriamycin-induced cardiotoxicity.
Wang Z; Chen Y; Gu M; Wu Z; Ding B; Yang W; Wu X; Wang C; Gao X; Yang Y; Yin G
Phytomedicine; 2022 Jul; 102():154178. PubMed ID: 35617889
[TBL] [Abstract][Full Text] [Related]
10. FGF1 protects neuroblastoma SH-SY5Y cells from p53-dependent apoptosis through an intracrine pathway regulated by FGF1 phosphorylation.
Pirou C; Montazer-Torbati F; Jah N; Delmas E; Lasbleiz C; Mignotte B; Renaud F
Cell Death Dis; 2017 Aug; 8(8):e3023. PubMed ID: 29048426
[TBL] [Abstract][Full Text] [Related]
11. Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2.
Wang A J; Tang Y; Zhang J; Wang B J; Xiao M; Lu G; Li J; Liu Q; Guo Y; Gu J
Redox Biol; 2022 Jun; 52():102310. PubMed ID: 35452917
[TBL] [Abstract][Full Text] [Related]
12. Intracellular FGF1 protects cells from apoptosis through direct interaction with p53.
Lampart A; Krowarsch D; Biadun M; Sorensen V; Szymczyk J; Sluzalska K; Wiedlocha A; Otlewski J; Zakrzewska M
Cell Mol Life Sci; 2023 Oct; 80(10):311. PubMed ID: 37783936
[TBL] [Abstract][Full Text] [Related]
13. [Protective effect of quercetin against adriamycin-induced cardiotoxicity and its mechanism in mice].
Pei TX; Xu CQ; Li B; Zhang ZR; Gao XX; Yu J; Li HZ; Yang BF
Yao Xue Xue Bao; 2007 Oct; 42(10):1029-33. PubMed ID: 18229606
[TBL] [Abstract][Full Text] [Related]
14. PPARγ Mediates the Anti-Epithelial-Mesenchymal Transition Effects of FGF1
Wang D; Zhao T; Zhao Y; Yin Y; Huang Y; Cheng Z; Wang B; Liu S; Pan M; Sun D; Wang Z; Zhu G
Front Pharmacol; 2021; 12():690535. PubMed ID: 34149434
[TBL] [Abstract][Full Text] [Related]
15. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
[TBL] [Abstract][Full Text] [Related]
16. Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity.
Yoshida M; Shiojima I; Ikeda H; Komuro I
J Mol Cell Cardiol; 2009 Nov; 47(5):698-705. PubMed ID: 19660469
[TBL] [Abstract][Full Text] [Related]
17. FGF1
Tang Q; Cheng Z; Liu S; Niu J; Xu J; Huang J; Pan J; Lu F; Chen D
Biochem Pharmacol; 2024 Mar; 221():116039. PubMed ID: 38301966
[TBL] [Abstract][Full Text] [Related]
18. Novel Muscle-Homing Peptide FGF1 Conjugate Based on AlphaFold for Type 2 Diabetes Mellitus.
Zhou J; Chen X; Chen Q; Pan B; Lou J; Jia Z; Du Y; Xu W; Zhang L; Feng X; Jin L; Shi M; Li X; Huang Z; Sun J
ACS Appl Mater Interfaces; 2023 Feb; 15(5):6397-6410. PubMed ID: 36625595
[TBL] [Abstract][Full Text] [Related]
19. Adriamycin induces cardiac fibrosis in mice via PRMT5-mediated cardiac fibroblast activation.
Dong XL; Yuan BH; Yu SZ; Liu H; Pan XH; Sun J; Pan LL
Acta Pharmacol Sin; 2023 Mar; 44(3):573-583. PubMed ID: 36056082
[TBL] [Abstract][Full Text] [Related]
20. FGF1 nuclear translocation is required for both its neurotrophic activity and its p53-dependent apoptosis protection.
Rodriguez-Enfedaque A; Bouleau S; Laurent M; Courtois Y; Mignotte B; Vayssière JL; Renaud F
Biochim Biophys Acta; 2009 Nov; 1793(11):1719-27. PubMed ID: 19765618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
